A61P 25/14
Drugs for disorders of the nervous system: for treating abnormal movements
Official title: for treating abnormal movements, e.g. chorea, dyskinesia
A61P25/14 (Drugs for disorders of the nervous system: for treating abnormal movements) appears on 14,897 US grants and 23,865 published applications in this corpus.
Search patents in A61P- Granted patents
- 14,897
- Published applications
- 23,865
- Assignees
- 5,330
- Inventors
- 32,032
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 3 | 0 |
| 1992 | 5 | 0 |
| 1993 | 4 | 0 |
| 1994 | 9 | 0 |
| 1995 | 22 | 0 |
| 1996 | 22 | 0 |
| 1997 | 53 | 0 |
| 1998 | 83 | 0 |
| 1999 | 102 | 0 |
| 2000 | 139 | 0 |
| 2001 | 234 | 77 |
| 2002 | 289 | 459 |
| 2003 | 315 | 765 |
| 2004 | 281 | 986 |
| 2005 | 298 | 1026 |
| 2006 | 432 | 1030 |
| 2007 | 455 | 1063 |
| 2008 | 489 | 1250 |
| 2009 | 606 | 1360 |
| 2010 | 759 | 1727 |
| 2011 | 785 | 1493 |
| 2012 | 917 | 1393 |
| 2013 | 992 | 1078 |
| 2014 | 992 | 1152 |
| 2015 | 933 | 1102 |
| 2016 | 777 | 1055 |
| 2017 | 810 | 974 |
| 2018 | 723 | 919 |
| 2019 | 692 | 996 |
| 2020 | 622 | 786 |
| 2021 | 533 | 705 |
| 2022 | 392 | 598 |
| 2023 | 331 | 566 |
| 2024 | 308 | 529 |
| 2025 | 324 | 464 |
| 2026 | 159 | 312 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin6 Oct 2026US 12,751,960 B2Compass Pathfinder Limited
- Methods of reducing neuroinflammation6 Oct 2026US 12,751,994 B2ImmunityBio, Inc.
- Compound and composition for preventing or treating neuroinflammatory brain diseases comprising same as active ingredient6 Oct 2026US 12,753,186 B2Korea Institute of Ocean Science & Technology
- HTT repressors comprising a zinc-finger protein transcription factor29 Sep 2026US 12,747,273 B2Sangamo Therapeutics, Inc.
- Methods and compositions for treating neurodegenerative diseases22 Sep 2026US 12,740,995 B2Augusta University Research Institute, Inc.
- Methods of determining glucose hypometabolism-induced energy crisis and treatments thereof8 Oct 2026US 2026/0306018 A1Senovia Biosciences LLC
- Subcutaneously administered treatments for advanced parkinson’s disease8 Oct 2026US 2026/0306517 A1AbbVie Inc.
- Intra-striatal co-transplantation of autologous treg and mda cells in parkinson's disease cell therapy8 Oct 2026US 2026/0306543 A1The McLean Hospital Corporation
- Modified adeno-associated virus vector and use thereof in treating neurological diseases8 Oct 2026US 2026/0306673 A1Genecombio Ltd.
- Oxysterols and methods of use thereof8 Oct 2026US 2026/0308197 A1Sage Therapeutics, Inc.
Most cited
By later US patents
- Modular infusion device and method1,554US 6,749,587 B2Insulet Corporation · 2004
- Biocompatible devices with foam scaffolds984US 6,054,142 ACyto Therapeutics, Inc. · 2000
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Biodegradable botulinum toxin implant657US 6,506,399 B2Allergan Sales, Inc. · 2003